Items where Funder is Breast Cancer UK Ltd.

Export as [feed] Atom [feed] RSS
Group by: Grant number | Institution | No Grouping
Number of items: 11.

119632

Leif, F, Pfänder, P, Murtuza Baker, S et al. (8 more authors) (2019) Nuclear receptor profiling predicts chemical disruptors as risk factors for developing breast cancer. In: Endocrine Abstracts (2019). Society for Endocrinology BES 2019, 11-13 Nov 2019, Brighton, UK. Society for Endicronology .

3T57/733

Solheim, S, Hutchinson, SA, Lundanes, E et al. (3 more authors) (2019) Fast liquid chromatography-mass spectrometry reveals side chain oxysterol heterogeneity in breast cancer tumour samples. Journal of Steroid Biochemistry and Molecular Biology, 192. 105309. ISSN 0960-0760

BB/R000352/1

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

Equipment Grant

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

MC_PC_15055

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

N/A

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

Not Known

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

P01703-471

Leif, F, Pfänder, P, Murtuza Baker, S et al. (8 more authors) (2019) Nuclear receptor profiling predicts chemical disruptors as risk factors for developing breast cancer. In: Endocrine Abstracts (2019). Society for Endocrinology BES 2019, 11-13 Nov 2019, Brighton, UK. Society for Endicronology .

RF_MA_Oxy/PO 1605-382

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

Solheim, S, Hutchinson, SA, Lundanes, E et al. (3 more authors) (2019) Fast liquid chromatography-mass spectrometry reveals side chain oxysterol heterogeneity in breast cancer tumour samples. Journal of Steroid Biochemistry and Molecular Biology, 192. 105309. ISSN 0960-0760

This list was generated on Fri May 3 04:21:25 2024 BST.